Sante Tura

Q: What Schools Are Affiliated With Sante Tura

Sante Tura is affiliated with the following schools: University of Parma, University of Bari, University of Bologna, Duke University

Sante Tura's AcademicInfluence.com Rankings

Sante Tura

Philosophy

#6496

World Rank

#9541

Historical Rank

Logic

#3650

World Rank

#4842

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Sante Tura Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sante Tura's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. (2002) (1196)
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. (2002) (1068)
Prognostic discrimination in "good-risk" chronic granulocytic leukemia (1984) (664)
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. (2002) (574)
Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. (1994) (535)
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. (1984) (504)
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. (2002) (432)
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. (1999) (414)
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. (2005) (390)
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study. (2007) (365)
Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres (2001) (337)
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders. (2001) (322)
Molecular Characterization of a Non–Babesia divergens Organism Causing Zoonotic Babesiosis in Europe (2003) (318)
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. (1995) (285)
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. (1999) (281)
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. (1991) (270)
Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. (2004) (267)
Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. (1997) (222)
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients. (2000) (214)
Staging and prognosis in chronic myelogenous leukemia. (1988) (212)
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia (1999) (204)
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect (1988) (194)
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology. (2002) (193)
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders (2008) (189)
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. (2004) (183)
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. (2005) (178)
The role of positron emission tomography (PET) in the management of lymphoma patients. (1999) (178)
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients (1990) (177)
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. (1996) (177)
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma. (2000) (171)
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. (2002) (167)
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. (1997) (166)
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia. (2002) (163)
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. (1999) (160)
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. (1999) (157)
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy. (2002) (156)
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia (1996) (142)
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. (2002) (140)
DIFFERENTIATION OF MYELOID LEUKAEMIC CELLS: NEW POSSIBILITIES FOR THERAPY (1979) (140)
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. (2004) (140)
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. (1997) (136)
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study. (1996) (135)
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. (2003) (133)
High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate (1997) (130)
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. (2002) (127)
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. (1988) (125)
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. (2003) (125)
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. (1997) (124)
Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. (1982) (124)
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients. (1998) (123)
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. (1985) (122)
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. (1997) (121)
Prevalence of Monoclonal Gammopathies in Patients with Hepatitis C Virus Infection (1998) (118)
Consensus conference on the management of tumor lysis syndrome (2008) (117)
Cell therapy: achievements and perspectives. (1999) (116)
Anaplastic large cell lymphoma (CD30+/Ki‐1+): results of a prospective clinico‐pathological study of 69 cases (1994) (116)
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. (2010) (113)
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure (2004) (111)
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L‐asparaginase during induction therapy: A retrospective study (1992) (110)
Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma (2005) (107)
Staging of Chronic Myeloid Leukaemia (1981) (102)
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. (1996) (100)
Primary bone lymphoma: experience with 52 patients. (2003) (99)
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma. (2000) (98)
Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation. (1991) (98)
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells (1998) (97)
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma. (2000) (94)
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. (2006) (92)
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? (1995) (92)
3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. (1999) (91)
Antitumor vaccination: where we stand. (2000) (91)
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. (1991) (91)
Interleukin-11 induces Th2 polarization of human CD4(+) T cells. (2001) (90)
Increase in Ty Lymphocytes in B‐Cell Chronic Lymphocytic Leukaemia (1981) (89)
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy. (2000) (88)
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients. (2000) (87)
Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. (2001) (86)
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). (2004) (82)
Deferasirox for transfusion‐dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial) (2014) (82)
Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making (2013) (81)
Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience. (1999) (80)
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. (2004) (79)
In vivo and in vitro inhibitory effect of α‐interferon on megakaryocyte colony growth in essential thrombocythaemia (1989) (78)
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure (2000) (76)
Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia. (1983) (75)
Generation and functional characterization of human dendritic cells derived from CD34+ cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells (1998) (74)
Staging of chronic lymphocytic leukemia. (1982) (73)
Extranodal Marginal Zone B-cell Lymphoma of MALT-type of the Lung: Single-center Experience with 12 Patients (2003) (73)
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. (1993) (73)
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia – analysis of 848 patients (2001) (71)
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. (1993) (70)
Fludarabine‐containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients (1999) (68)
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study (2002) (68)
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. (1993) (67)
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. (2001) (66)
Classical Hodgkin’s lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up (2009) (66)
Overexpression of multidrug resistance‐associated p170‐glycoprotein in acute non‐lymphocytic leukemia (1992) (65)
Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR− Dendritic Cell Precursors (2001) (65)
Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation (2011) (65)
Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patients. (1998) (64)
T‐cell functional abnormality in B‐chronic lymphocytic leukaemia: evidence of a defect of the T‐helper subset (1983) (64)
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone. (2006) (64)
Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases. (1997) (63)
Mediastinal large B‐cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third‐generation regimens (1995) (62)
Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on ‘in vitro’ growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors (1997) (62)
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation. (1987) (61)
Fludarabine treatment in resistant Waldenstrom's macroglobulinemia (1995) (61)
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients. (1998) (59)
Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells. (1994) (58)
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma (1998) (57)
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. (1997) (57)
Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa (1993) (57)
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. (2001) (57)
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells (1999) (57)
Is interferon alpha in cutaneous T‐cell lymphoma a treatment of choice? (1991) (56)
Alpha recombinant interferon in the treatment of mycosis fungoides (MF). (1987) (56)
Hypercoagulability during l‐asparaginase treatment: the effect of antithrombin III supplementation in vivo (1990) (55)
Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. (1996) (54)
Prognostic value of serum IL‐10 and soluble IL‐2 receptor levels in aggressive non‐Hodgkin's lymphoma (1994) (53)
Acute promyelocytic leukemia: clinical aspects and results of treatment in 62 patients. (1987) (52)
Prognostic variables and clinical staging in multiple myeloma. (1989) (52)
Comparison of prognostic models in patients with advanced Hodgkin disease (2001) (52)
Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients. (1997) (51)
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. (2003) (51)
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey (1997) (50)
Stem cell plasticity: time for a reappraisal? (2005) (50)
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow (2003) (50)
Expression and functional role of c‐kit ligand (SCF) in human multiple myeloma cells (1994) (49)
Clinical implications of cytokine and soluble receptor measurements in patients with newly‐diagnosed aggressive non‐Hodgkin's lymphoma (1995) (49)
A chromosomal abnormality in primary thrombocythemia. (1978) (49)
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation (2000) (49)
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study. (2002) (48)
First‐line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma (2006) (48)
Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. (2006) (47)
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. (2004) (47)
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. (1998) (47)
Core needle biopsy is effective in the initial diagnosis of mediastinal lymphoma. (1999) (47)
Myelodysplastic syndromes: recent advances. (2001) (46)
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma. (1997) (46)
Decreased Pasteur effect in platelets of aged individuals (2001) (46)
GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy. (1990) (45)
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients. (2002) (45)
Detection of soluble interleukin‐2 receptor and interleukin‐10 in the serum of patients with aggressive non‐Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure (1994) (45)
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. (2005) (45)
The importance of endoscopic ultrasonography in the management of low‐grade gastric mucosa‐associated lymphoid tissue lymphoma (2002) (44)
Endothelium and bone marrow transplantation. (1996) (44)
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation. (2001) (43)
Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage. (2002) (42)
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas. (2000) (42)
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation. (2000) (42)
Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups (2013) (41)
Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases (1985) (41)
Pulsed ATRA as single therapy restores long-term remission in PML-RARα-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study (2001) (41)
Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation. (1999) (40)
Apoptosis induction with three nucleoside analogs on freshly isolated B‐chronic lymphocytic leukemia cells (1994) (40)
Chronic idiopathic thrombocytopenic purpura (ITP): site of platelet sequestration and results of splenectomy. A study of 197 patients. (2009) (39)
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. (1996) (39)
Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin's disease in long‐lasting remission (1983) (39)
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. (2006) (38)
Advantages of Positron Emission Tomography (PET) with Respect to Computed Tomography in the Follow-up of Lymphoma Patients with Abdominal Presentation (2002) (38)
Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications (1994) (38)
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients. (2000) (38)
Histology and immunohistology of bone marrow biopsy in multiple myeloma (1989) (38)
Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies. (2000) (38)
An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients. (1989) (37)
Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease. (1984) (37)
A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients. (1996) (37)
Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli-asparaginase. A Gimema study (1994) (36)
Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemia (1993) (36)
All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. (1996) (36)
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low‐grade non‐Hodgkin's lymphoma (1995) (35)
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. (1987) (35)
Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. (1998) (35)
Nonsecretory Multiple Myeloma (1985) (35)
Treatment‐related leukemia in Hodgkin's disease: A multi‐institution study on 75 cases (1987) (35)
FLAG (Fludarabine, Cytarabine, G‐CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects (1996) (34)
Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. (1999) (34)
Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation (1992) (33)
Adult acute lymphoblastic leukaemia: study of 32 patients and analysis of prognostic factors. (2009) (33)
Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. (1996) (33)
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis. (1998) (33)
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma (2013) (32)
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia (2000) (32)
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients. (1999) (32)
Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints. (2000) (32)
Interleukin-9 stimulates the proliferation of human myeloid leukemic cells. (1996) (32)
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. (2009) (32)
Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. (1996) (32)
Efficacy of rituximab in hairy cell leukemia treatment. (2000) (32)
Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma. (1997) (31)
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). (2015) (31)
Superiority of Double over Single Autologous Stem Cell Transplantation as First-Line Therapy for Multiple Myeloma. (2004) (31)
Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter] (1996) (31)
Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia [letter] (1994) (31)
Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. (1992) (31)
Bone marrow transplantation for chronic lymphocytic leukemia. (1991) (30)
Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia. (1980) (30)
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma (2012) (30)
Ex vivo expansion of hematopoietic cells and their clinical use. (1998) (30)
2‐Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders (1997) (30)
T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells (1998) (30)
Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia (1982) (29)
Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia (2000) (29)
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation (2009) (29)
Heterogeneity of large granular lymphocyte proliferations: morphological, immunological and molecular analysis in seven patients (1987) (29)
Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosis. (1985) (29)
Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid. (2005) (29)
Prostaglandin E2 in the treatment of oral mucositis due to radiochemotherapy in patients with haematological malignancies. (1989) (29)
Long‐term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group (1994) (28)
Rapid induction of CD40 on a subset of granulocyte colony-stimulating factor-mobilized CD34(+) blood cells identifies myeloid committed progenitors and permits selection of nonimmunogenic CD40(-) progenitor cells. (1999) (28)
Bone marrow transplantation in multiple myeloma. (2009) (27)
Treatment of hairy-cell leukaemia with α-interferon (α-IFN) (1988) (27)
Cycling Status of CD 34 " Cells Mobilized Into Peripheral Blood of Healthy Donors by Recombinant Human Granulocyte Colony-Stimulating Factor (1997) (27)
VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly. (1993) (27)
Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies. (1994) (27)
Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper. (2014) (27)
Selection and transplantation of autologous CD34+ B‐lineage negative cells in advanced‐phase multiple myeloma patients: a pilot study (1999) (27)
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow. (1998) (27)
Early detection of bone marrow engraftment by amplification of hypervariable DNA regions. (1997) (26)
Molecular analysis of PML‐RARa fusion mRNA detected by reverse transcription‐polymerase chain reaction assay in long‐term disease‐free acute promyelocytic leukaemia patients (1995) (26)
Allogeneic bone marrow transplantation in multiple myeloma. (1992) (26)
Rapid restoration of natural killer activity following treatment with 2‐chlorodeoxyadenosine in 22 patients with hairy‐cell leukemia (1994) (26)
Letter: Splenic lymphocytes in chronic myeloid leukaemia. (1974) (26)
All‐trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia (2000) (26)
A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase. (1991) (26)
The presence of lymphoid‐associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance (1995) (26)
Acute promyelocytic leukemia: results of therapy and analysis of 13 cases. (1977) (26)
Peripheral blood stem cell transplantation for the treatment of multiple myeloma: biological and clinical implications. (1996) (25)
Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. (1994) (25)
Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro (1998) (25)
A prospective comparison of α-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients (1992) (25)
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies. (1997) (25)
Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. (1981) (24)
Molecular therapy for multiple myeloma. (2001) (24)
Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. (1996) (24)
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells. (1999) (24)
Autologous bone marrow transplantation with immunotoxin‐purged marrow for advanced multiple myeloma (1989) (24)
Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology. (2017) (24)
Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis. (2002) (24)
Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation. (1991) (24)
Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement. (1999) (24)
Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations. (1989) (24)
Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia. (1996) (24)
Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation (2002) (23)
Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma (1983) (23)
Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells. (1994) (23)
Alternative BCR/ABL transcripts in chronic myeloid leukemia. (1990) (23)
Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low‐grade non‐Hodgkin's lymphoma (1996) (23)
Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. (1994) (23)
Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma. (1996) (22)
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications. (1996) (22)
Early splenectomy and polychemotherapy versus polychemotherapy alone in chronic myeloid leukemia. (1981) (22)
Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods (1998) (22)
Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis. (1993) (22)
Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera (2018) (22)
All-Trans Retionic ACid in the Treatment of Myelodysplastic Syndromes (1995) (22)
Granulocytic sarcomas: clinical, diagnostic and therapeutical aspects. (1997) (22)
Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation. (1987) (22)
High‐dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non‐Hodgkin's lymphoma (1986) (22)
Increased serum levels of transforming growth factor β‐1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis (1993) (21)
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. (1998) (21)
Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes. (2017) (21)
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients. (2002) (21)
Alternative BCR/ABL transcripts in chronic myeloid leukemia [letter; comment] (1990) (21)
FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphoma. (1996) (21)
Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell‐associated antigens: Effects on target cells and on normal myeloid precursors (CFU‐GM) (1989) (21)
Superiority of First-Line Thalidomide-Dexamethasone over Vincristine-Doxorubicin-Dexamethasone in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma. (2004) (21)
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases. (1990) (21)
3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas. (1997) (21)
Meningitis and septicaemia in adults splenectomized for Hodgkin's disease. (2009) (20)
Guidelines for the use of recombinant human erythropoietin. (1994) (20)
Pathogenesis and progression of chronic myeloid leukemia. (1996) (20)
Four‐chromosomes complex translocations in acute promyelocytic leukemia: Description of two cases (1994) (20)
The type of BCR/ABL junction does not predict the survival of patients with Ph1‐positive chronic myeloid leukaemia (1993) (20)
Recombinant interleukin‐2 (rIL‐2) in acquired immune deficiency syndrome (AIDS): Preliminary report in patients with lymphoma associated with HIV infection (1992) (20)
The inhibitory effect of serum from hairy‐cell leukaemia patients on normal progenitor cells may disappear following prolonged treatment with α‐interferon (1989) (20)
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects. (1997) (20)
Chronic myeloid leukemia. (1986) (20)
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice (2015) (20)
Long‐term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow‐up of 7 years (1991) (20)
All-trans retinoic acid and induction of apoptosis in acute promyelocytic leukemia cells. (1994) (19)
In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells. (1999) (19)
Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients. (1986) (19)
Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α (1996) (19)
In vitro treatment with retinoids decreases bcl‐2 protein expression and enhances dexamethasone‐induced cytotoxicity and apoptosis in multiple myeloma cells (1999) (19)
Characterization of T‐lymphocyte subsets in hairy‐cell leukaemia (HCL) by monoclonal antibodies: comparison with Fcγ, Fcμ receptors and correlation with disease activity (1982) (19)
Primary gastric lymphoma: a clinical and therapeutic evaluation of 82 patients. (1995) (18)
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells. (1999) (18)
Interleukin‐11 (IL‐11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells (1995) (18)
Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells. (1999) (18)
Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant. (2003) (18)
Reduction of heat‐shock protein‐70 after prolonged treatment with retinoids: Biological and clinical implications (1997) (18)
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma. (1994) (18)
Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative molecular remission in relapsed P-190BCR-ABL-positive acute lymphoblastic leukemia (2002) (18)
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology. (1990) (18)
ALL‐TRANS RETINOIC ACID IMPROVES ERYTHROPOIESIS IN MYELODYSPLASTIC SYNDROMES: A CASE REPORT (1992) (17)
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy (2000) (17)
Allogeneic bone marrow transplantation for the treatment of multiple myeloma: An overview of published reports (1995) (17)
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. (2014) (17)
Recombinant alpha-2a interferon (alpha-IFN) in the treatment of essential thrombocythaemia. Preliminary report. (1987) (17)
Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case report (1999) (17)
A sensitive test for the detection of NK activity. Plasma clot clonogenic assay. (1988) (17)
High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation. (1994) (17)
Platelet function and interferon alpha‐2a treatment in essential thrombocythaemia (1991) (17)
Growth patterns, cell composition, and mitotic activity of granulocytic aggregates developing in methyl cellulose from human normal marrow cells. (1979) (17)
Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma. (1975) (17)
Meningeal leukemia complicating prolymphocytoid transformation of B-chronic lymphocytic leukemia. (1985) (17)
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. (1995) (17)
Results of a fludarabine induction and α‐interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low‐grade non‐Hodgkin's lymphoma (1997) (16)
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. (2000) (16)
Long‐term survival in adolescent and adult acute lymphoblastic leukemia (2006) (16)
Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation. (2000) (16)
CLOSE ASSOCIATION BETWEEN ANTIBODIES TO CYTOSKELETAL INTERMEDIATE FILAMENTS, AND CHRONIC GEAFT‐VERSUS‐HOST DISEASE (1987) (16)
Dendritic cell differentiation from hematopoietic CD34+ progenitor cells. (2001) (16)
Ki-1 lymphoma and Hodgkin's disease. (1989) (16)
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis (2002) (16)
Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1). (2002) (16)
Autoimmune neutropenia after unrelated bone marrow transplantation. (1994) (16)
Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. (1995) (16)
Hodgkin's disease (HD): a historical perspective. (1986) (16)
Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the ebmt registry (1988) (16)
Molecular analysis of granulocytic sarcoma: a single center experience. (1999) (16)
High Fibrinopeptide A (FPA) Levels in Acute Non-Lymphocytic Leukemia Are Reduced by Heparin Administration (1984) (15)
Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562 * (1993) (15)
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation. (1996) (15)
Impairment of GM‐CSF production in myelodysplastic syndromes (1993) (15)
Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator. (1994) (15)
Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission. (1998) (15)
All-trans retinoic acid in the treatment of myelodysplastic syndromes. (1995) (15)
Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone. (1980) (15)
Depressed fibrinolysis in patients with acute leukaemia (1987) (15)
High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. (1993) (15)
Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade. (2003) (15)
A simultaneous study of bone marrow, spleen, and liver in chronic myeloid leukemia: evidence for differences in cell composition and karyotypes. (1975) (15)
Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia. (1988) (15)
Efficacy of the VBM regimen in the treatment of elderly patients with Hodgkin's disease. (2000) (15)
Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation (1999) (15)
Bone marrow transplantation in multiple myeloma: current status and future perspectives. (1986) (14)
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia. (1992) (14)
Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment. (1992) (14)
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group. (2014) (14)
M‐2 protocol for melphalan‐resistant and relapsing multiple myeloma (1988) (14)
All‐trans retinoic acid and in vitro cytokine production by acute promyelocytic eukemia cells (1996) (14)
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper. (2015) (14)
Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report. (1991) (14)
Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studies. (1984) (14)
Biological characterization of CD34+ cells mobilized into peripheral blood. (1998) (14)
Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia. (2001) (13)
Prognostic significance of lymphography in stage IIIs Hodgkin's disease (HD). (1984) (13)
Reduced hematologic response to alpha‐interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype (1990) (13)
Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukaemia in chronic phase: a comparison of transplant versus no‐transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986 (1993) (13)
21q− in primary thrombocythemia☆ (1980) (13)
HIGH-DOSE MELPHALAN FOR MULTIPLE MYELOMA (1983) (13)
Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia (2002) (13)
Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia. (2000) (13)
Concamitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient (1999) (13)
t(8;14)(q11;q32) in acute lymphoid leukemia: description of two cases. (1993) (13)
Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferation. (1989) (13)
ALLOGENEIC BONE MARROW TRANSPLANTATION FOR SECONDARY LEUKAEMIA AND MYELODYSPLASTIC SYNDROME (1990) (13)
Antiangiogenic Therapy in Multiple Myeloma (2001) (13)
Retreatment with 2-CdA of progressed HCL patients. (1994) (12)
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors (1995) (12)
Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy. (1998) (12)
Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma. (1993) (12)
Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients. (2001) (12)
Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura. (1996) (12)
Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow (1998) (12)
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells (2000) (12)
Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura. (1998) (12)
Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells. (1997) (12)
Interleukin-9 in human myeloid leukemia cells. (1997) (12)
Peripheral blood mobilization of hematopoietic stem cells: cytokine-mediated regulation of adhesive interactions within the hematopoietic microenvironment. (1997) (12)
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. (1999) (12)
Hydroxyurea enhances 3′‐azido‐3′‐deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models * (1994) (12)
Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha. (1996) (11)
Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. (2019) (11)
Allogeneic bone marrow transplantation in patients with multiple myeloma (1989) (11)
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia. (1992) (11)
Chemotherapy of Secondary Leukemias (2000) (11)
Non-Hodgkin's lymphomas in leukaemic phase: incidence, prognosis and therapeutic implications. (2009) (11)
Acquired Storage Pool Disease in Myeloproliferative Disorders (1979) (11)
MEASURING CYCLOSPORIN IN PLASMA (1983) (11)
All‐trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines (1999) (11)
Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma. (2001) (11)
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study (1999) (11)
Interleukin-11 induces Th 2 polarization of human CD 4 1 T cells (2001) (11)
Recombinant α‐interferon 2b in the treatment of HIV‐related thrombocytopenia (1993) (11)
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens fare in the long-term? (1999) (10)
Deferasirox Chelation Therapy in Transfusion Dependent MDS Patients. Final Report From the Gimema MDS0306 Prospective Trial (2012) (10)
Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non‐Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper (2016) (10)
The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myeloma. (1995) (10)
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience. (2003) (10)
Comparison of the DNA Content, Bromodeoxyuridine Incorporation and Ki-67 Antigen Expression in Human Acute Myeloid Leukemia. (1990) (10)
Procedure for the quantitation of Gadd45 expression levels in clonal hematopoietic progenitor cells by competitive polymerase chain reaction. (1999) (10)
Megakaryocyte progenitors derived from bone marrow or G‐CSF‐mobilized peripheral blood CD34+ cells show a distinct phenotype and responsiveness to interleukin‐3 (IL‐3) and PEG‐recombinant human megakaryocyte growth and development factor (PEG‐rHuMGDF) (1998) (10)
Bone marrow necrosis by diffuse metastatic intravascular obstruction. (1982) (10)
Membrane phenotype and functional behaviour of T lymphocytes in hairy cell leukemia (HCL). (1984) (10)
MACOP-B Regimen Followed by Involved-Field Radiation Therapy in Early-Stage Aggressive Non-Hodgkin's Lymphoma Patients: 14-Year Update Results (2001) (10)
Hairy-cell leukemia and alpha-interferon treatment: long-term responders. (1997) (10)
Differences in marrow and spleen cell karyotype in early chronic myeloid leukaemia. (1975) (10)
Low doses of rIL2 after autologous bone marrow transplantation induce a “prolonged” immunostimulation of NK compartment in high-grade non-Hodgkin's lymphomas (1995) (10)
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases. (2006) (10)
Pulmonary disease in patients with hematologic malignancies. (2002) (10)
Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis. (2000) (10)
Biological markers and minimal residual disease in hairy cell leukemia. (1992) (10)
An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia. (1999) (10)
Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia. (1994) (9)
Hodgkin's disease: controversies and challenges for the future. (1991) (9)
An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells (2004) (9)
Defibrination in adult acute lymphoblastic leukaemia. Report of four cases. (1980) (9)
Peptichemio in multiple myeloma. (Preliminary results). (1981) (9)
Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets (1999) (9)
Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2) (1999) (9)
Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation. (1996) (9)
BONE MARROW PURGING FOR MULTIPLE MYELOMA BY AVIDIN‐BIOTIN IMMUNOADSORPTION (1989) (9)
FLAG (fludarabine + cytosine arabinoside + G‐CSF) induces complete remission in acute‐phase chronic myeloid leukaemia: a case report (1994) (9)
Detection of clonality by heteroduplex analysis of amplified junctional region of T-cell receptor gamma in patients with T-cell acute lymphoblastic leukemias. (1997) (9)
Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients. (1993) (9)
Acute nonlymphocytic leukemias and dysmyelopoietic syndromes in patients treated for Hodgkin's lymphoma. (1983) (9)
Clinical contribution to the knowledge of hemopoietic dysplasias: long-term follow-up of 13 patients with refractory anemia. (1978) (9)
Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells. (1995) (9)
Long-term disease-free acute myeloblastic leukemia with inv(16) is associated with PCR undetectable CBFbeta/MYH11 transcript. (2000) (9)
Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures (1999) (9)
BCR breakpoint subregions and blast crisis lineage in CML patients. (1992) (9)
Allogenic BMT for multiple myeloma (MM). The Italian experience. (1991) (9)
Interleukin‐4 Downregulates Nuclear Factor‐Erythroid 2 (NF‐E2) Expression in Primary Megakaryocytes and in Megakaryoblastic Cell Lines (2001) (9)
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia. (2012) (9)
Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia. (1991) (8)
To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single center. (1998) (8)
Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group. (1994) (8)
Cell kinetic effect of low dose arabinosyl cytosine (1987) (8)
Procoagulant cellular activity (PCA) in the classification of acute leukemia. (1987) (8)
Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission. (1998) (8)
Results in hairy‐cell leukemia patients treated with α‐interferon: Predictive prognostic factors (1992) (8)
Pulmonary Emphysema and Polycythemia Induced in Rats by Forced Swimming.∗ (1960) (8)
IMMUNOGLOBULIN GENE REARRANGEMENTS IN HUMAN MULTIPLE MYELOMA (1989) (8)
T-cell prolymphocytic leukaemia: a clinical and immunological study. (2009) (8)
PHILADELPHIA-CHROMOSOME-POSITIVE PRELEUKÆMIC STATE (1973) (8)
Arabinosyl cytosine in chronic myeloid leukaemia: evidence for high cytokinetic sensitivity of myeloblasts. (2009) (8)
Alpha-interferon in the treatment of chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. (1995) (8)
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. (2003) (8)
In situ staining of bromodeoxyuridine positive cells in normal and neoplastic colony-forming units grown on plasma clots. (1988) (8)
Adult Burkitt's lymphoma: clinical and prognostic evaluation of 20 patients. (1994) (8)
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia. (1995) (8)
FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia. (1996) (8)
Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia. (1991) (8)
Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data. (1994) (8)
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients (2001) (8)
BONE MARROW PLASMA CELL INFILTRATION IN MULTIPLE MYELOMA (1984) (7)
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term? (1999) (7)
Hematologic, cytogenetic and molecular response to Glivec (STI571) in Ph+ chronic myeloid leukemia (CML) in accelerated and blastic phase: a prospective study of the Italian cooperative study group on CML (2001) (7)
In vitro culture with prednisolone increases BCL‐2 protein expression in adult acute lymphoblastic leukemia cells (1996) (7)
Relationship of serum lactate dehydrogenase level with first remission length in adult acute lymphocytic leukaemia (1987) (7)
Allogeneic versus autologous bone marrox transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A) (1992) (7)
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas (2004) (7)
Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol. (1990) (7)
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group. (1992) (7)
The relevance of extramedullary hemopoiesis to the staging of chronic myeloid leukemia. (1978) (7)
Rapid Induction of CD 40 on a Subset of Granulocyte Colony-Stimulating Factor – Mobilized CD 34 1 Blood Cells Identifies Myeloid Committed Progenitors and Permits Selection of Nonimmunogenic CD 40 2 Progenitor Cells (1999) (7)
Human myeloid precursor cells do not possess or produce procoagulant activity (PCA). (1986) (7)
Lonidamine in the treatment of chronic lymphoid leukemia. (1984) (7)
Cep Regimen (Ccnu, Etoposide, Prednimustine) for Relapsed/Refractory Hodgkin's Disease (1994) (7)
ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease. (1999) (7)
T-cell subsets defined by monoclonal antibodies in autoimmune thrombocytopenic purpura (ATP). (1983) (7)
A prospective study of α-interferon and autologous bone marrow transplantation in chronic myeloid leukemia (1999) (7)
High-Dose Therapy with Autologous Transplantation for Aggressive Non-Hodgkin's Lymphoma: The Bologna Experience (2004) (7)
Mental depression, acute infection and coma in a patient treated with interferon-alpha. (1989) (7)
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease. (1995) (7)
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study (2012) (6)
Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia (1996) (6)
In Vitro Activity of Alpha-Interferon on Granulocyte-Macrophage Precursors in Chronic Myeloid Leukemia (CML): Correlation with Clinical Responsiveness (1992) (6)
Re-evaluation of prognosis in stages I and II Hodgkin's disease with bulky mediastinal involvement. (1987) (6)
CD7 expression does not affect the prognosis in acute myeloid leukemia. (1994) (6)
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency (2018) (6)
Prior treatment with a-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia (1998) (6)
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies. (1988) (6)
Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. (1984) (6)
COMBINATION CHEMOTHERAPY IN STAGES I OR II HODGKIN'S DISEASE (1979) (6)
Stage I high-grade non-Hodgkin's lymphomas: a retrospective analysis. (1991) (6)
Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP). (1992) (6)
Effectiveness of Fludarabine, Idarubicin and Cyclophosphamide (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin's Lymphoma (2004) (6)
SUPERINTENSIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA (1984) (6)
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia. (1994) (6)
Chromosome 12 rearrangement with breakage at the p11 level in hematologic disorders: report of four cases. (1985) (6)
Prognostic factors in chronic myeloid leukemia. Relationship with interferon and bone marrow transplantation. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. (1993) (6)
Cell flux studies during chemotherapy with multiple doses of arabinosyl cytosine in chronic myeloid leukemia (1977) (6)
2-Chlorodeoxyadenosine in psoriasis treatment. (1995) (6)
An unusual case of Candida tropicalis sepsis in a patient submitted to allogeneic bone marrow transplantation. (1990) (6)
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL). (1989) (6)
Ciclosporin A in idiopathic and CLL-associated pure red cell aplasia. (1987) (6)
Molecular analysis of HLA genes for the selection of unrelated bone marrow donor. (1995) (6)
Negative selection of autologous peripheral blood stem cells. (1999) (6)
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase (2020) (6)
Expression of P21WAF1/CIP1/SID1 cyclin-dependent kinase inhibitor in hematopoietic progenitor cells (2001) (5)
Normal T-Lymphocyte Function in Patients with Hodgkin's Disease in Long-Lasting Remission (1986) (5)
Recovery of CFU-GM after freezing of normal human bone marrow: effect of three dilution techniques after thawing. (1983) (5)
Does the type of BCR/ABL junction predict the survival of patients with Ph1-positive chronic myeloid leukemia? (1995) (5)
5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas. (1978) (5)
STEROID‐RESISTANT ACQUIRED PURE RED CELL APLASIA: A PARTIAL REMISSION INDUCED BY RECOMBINANT HUMAN ERYTHROPOIETIN (1991) (5)
Effect of 4-demethoxydaunorubicin (4-DMDR) in chronic myeloid leukemia in blastic transformation and relapsed acute leukemias. (1985) (5)
Efficacy of thalidomide in the treatment of myelodysplastic syndromes. (2002) (5)
New trends in the management of chronic myeloid leukaemia. (1972) (5)
Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line. (1998) (5)
Towards an increasingly molecular-based, patient-oriented treatment of acute myeloid leukemia. (1996) (5)
Autologous bone marrow transplantation with marrow cryopreserved for ten years. (1993) (5)
Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells. (1995) (5)
Chromosome studies in paroxysmal nocturnal haemoglobinuria. (1973) (5)
Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: effectiveness and tolerability. (1991) (5)
The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-alpha (IFN alpha). A collaborative European study of 317 cases. (2001) (5)
Advances in prognosis of chronic myeloid leukemia. (1992) (5)
Critical value of laparotomy with splenectomy in Stage III Hodgkin's disease as restaging procedure after chemotherapy (1988) (5)
Management of nodular sclerosis Hodgkin's disease stage I, II A and B: evidence for a beneficial effect of MOPP on the relapse rate. (1979) (5)
Retinoids increase idarubicin cytotoxicity in human myeloid leukemia cell lines (1996) (5)
MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B? (1991) (5)
Spinal cord compression in Hodgkin's disease. (1984) (5)
FINGERPRINTING OF HLA CLASS I GENES FOR IMPROVED SELECTION OF UNRELATED BONE MARROW DONORS (1996) (5)
Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission. (1977) (4)
Adenoviral mediated gene transfer can be accomplished in human myeloid cell lines and is inhibited by all-trans retinoic acid-induced differentiation. (1997) (4)
Imatinib Therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem Cell Transplantation: A Molecular Analysis. (2004) (4)
Treatment of Ph-Positive Chronic Myeloid Leukemia with α-Interferon (Roferon-A). The Italian Cooperative Study Group Experience (1993) (4)
'Fingerprinting' of HLA-DQA by polymerase chain reaction and heteroduplex analysis. (1996) (4)
Improvement of Durie & Salmon staging for multiple myeloma by adding platelet count as a stratifying variable: A multivariate regression analysis of 163 untreated patients (1989) (4)
Therapy of chronic myeloid leukemia (CML): interim report on protocols CML/73 and CML/74. (1978) (4)
Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapy. (1984) (4)
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha. (1996) (4)
Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma. (2000) (4)
Results in hairy-cell leukemia patients treated with alpha-interferon: predictive prognostic factors. (1992) (4)
Effect of early splenectomy and cyclic acute leukemia-like chemotherapy on the course of chronic myeloid leukemia. (1978) (4)
Importance of gallium scan restaging for curative treatment of mediastinal lymphomas. (2001) (4)
Anthracycline Containing Regimens in Intermediate Grade Lymphoma (1992) (4)
Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical cytogenetic and cell culture study. (1988) (4)
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase (1998) (4)
Consensus conference on the use of 90‐yttrium‐ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology (2010) (4)
Serial Chromosome Studies in Transplanted Ph1 + CML Patients (1985) (4)
Intrinsic factor and gastric juice secretion induced by pentagastrin. (1967) (4)
T lymphocyte subsets and colony growth in hairy-cell leukemia (1982) (4)
Amplification of third-complementary-determining-region (CDR-III) of heavy chain immunoglobulin gene (IgH) in one hundred adult acute leukemias. (1997) (4)
T gamma cell deficiency in idiopathic thrombocytopenic purpura (ITP). (1981) (4)
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation (2007) (4)
High‐dose chemoradiotherapy and allogeneic bone marrow transplantation in multiple myeloma (1989) (4)
Mycosis fungoides: a therapeutical review. (1991) (4)
Alpha‐2b recombinant interferon (Intron) in Hodgkin's lymphoma: Therapeutic perspective (1990) (4)
Acute leukemia in patients treated for Hodgkin's disease: report of two cases. (1979) (4)
Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level. (1998) (4)
Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: The value of early evaluation of the course of the disease (2005) (4)
Interferon in chronic myeloid leukemia (1993) (4)
Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation. (2005) (3)
New target of chronic lymphocytic leukemia treatment. (1994) (3)
Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity (1993) (3)
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon. (1992) (3)
Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM). (1988) (3)
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas. (1991) (3)
Thrombotic thrombocytopenic purpura: relapse and pregnancy. (1993) (3)
Lithium carbonate in haematology. (1980) (3)
All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. (1994) (3)
Allogeneic stem cell transplants for multiple myeloma. Bologna experience (1998) (3)
Therapy-related acute leukemia associated with involvement of 11q23 after high grade non-Hodgkin lymphoma. (1998) (3)
Chromosome studies in acute promyelocytic leukemia. An analysis of 11 cases. (1984) (3)
Relationship between immunological phenotype and hematological response to α‐IFN treatment in 35 patients with hairy cell leukemia (1990) (3)
Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors (1993) (3)
E‐rosette positive acute lymphoblastic leukaemia in adolescents and adults (1983) (3)
Intensive polychemotherapy experience in chronic myeloid leukaemia. (1989) (3)
Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia. (1991) (3)
The effect of chemotherapy (MOPP) following radiotherapy in stage I to III Hodgkin's disease: analysis of 110 cases. (1979) (3)
EVALUATION OF THROMBOPOIESIS IN ESSENTIAL THROMBOCYTHAEMIA BEFORE AND AFTER α-INTERFERON TREATMENT (1987) (3)
Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 cases. (1974) (3)
[Therapy and iron supplements with ferritin iron during pregnancy. Randomized prospective study of 458 cases]. (1989) (3)
Ceop Regimen in the Treatment of Advanced Low-Grade Non-Hodgkin's Lymphomas: Preliminary Report (1990) (3)
Long-term cryopreservation of autologous bone marrow: analysis of granulocyte-macrophage progenitor (CFU-GM) viability in 31 samples stored more than 48 months. (1988) (3)
Treatment of Ph+ chronic myeloid leukemia by gamma interferon (1989) (3)
The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory cases. (1997) (3)
Mitobronitol: An Alkylating Agent That Does Not Induce Extra Leukemia Cases if Applied as Pulse Therapy for Polycythemia Vera (1985) (3)
Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Serial chromosome studies in 5 patients. (1984) (3)
In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases. (1990) (3)
Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients. (1996) (3)
Lithium and Granulocytopenia during Induction Treatment of Adult Acute Lymphoblastic Leukemia (1982) (3)
Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes. (1992) (3)
Ph1-positive chronic myeloid leukaemia presenting in blastic crisis: report of 12 cases. (1978) (3)
2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II study. (1984) (3)
B-Cell Reconstitution After Allogeneic Bone Marrow Transplantation (ABMT) (1985) (2)
Sensitivity of Ph1+ CFU-GM to human recombinant interferon α and γ alone and in combination (1988) (2)
Nodal aggressive non-Hodgkin’s lymphoma in the adult: a review article (2005) (2)
Intensive Chemotherapy Regimen in High-Grade non Hodgkin's Lymphomas (1987) (2)
[Therapy of the blastic crisis]. (1972) (2)
Methotrexate and delayed engraftment in allogeneic bone marrow transplantation. (1995) (2)
Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I-B35 molecules: relationship between antigen defective cell lines and HLA frequencies in CML patients. (1995) (2)
Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT. (1989) (2)
The management of elderly patients with myeloproliferative disorders. (1993) (2)
Quantitative Evaluation of BCR-ABL Amount of Transcript Post Mobilization with G-CSF of Peripheral Blood Stem Cells from Chronic Myeloid Leukemia Patients in Cytogenetic Response (2000) (2)
Superintensive Therapy and Autologous Bone Marrow Transplantation (ABMT) in Malignant Lymphomas (Bologna Experience) (1985) (2)
Production and characterization of monoclonal antibodies (MoAbs) for the ex vivo purging of the bone marrow in patients with multiple myeloma. (1987) (2)
Long-term culture of chronic myeloid leukemia (CML) bone marrow cells. (1991) (2)
Serial Chromosome Studies in Transplanted Phl + CML Patients Sporadic Observation of Phi+ Cells after BMT (1985) (2)
Interferon in chronic myeloid leukemia. A workshop report. (1993) (2)
Philadelphia chromosome-positive acute lymphoid leukemias A phase 2 study of imatinib in patients with relapsed or refractory (2009) (2)
[Autologous bone marrow transplantation in acute lymphoblastic leukemia]. (1991) (2)
Mycosis fungoides. Prognostic evaluation on 45 patients. (1985) (2)
5q- and t(2;11) in a patient with M2 acute non-lymphocytic leukemia. Case report. (1989) (2)
Immunological markers in non-Hodgkin's lymphomas. (1979) (2)
Use of Lenalidomide in DEL(5q) MDS. a National AIFA (Agenzia Italiana del Farmaco) Registry Study (2015) (2)
[Splenectomy in the therapy of Hodgkin's lymphoma]. (1972) (2)
Long term survivors in adult acute lymphoblastic leukemia. (1989) (2)
[Quantitative determination of intrinsic factor after stimulation of the gastric mucosa with protein hydrolysate]. (1966) (2)
Avidin-biotin immunoadsorption for ex vivo bone marrow purging: effect of percentage of target cells and flow rate. (1988) (2)
[Mechanism of splenic involvement in Hodgkin's lymphoma]. (1972) (2)
TdT in adult acute lymphoblastic leukemia: relationship with blast cell count. (1981) (2)
Nervous system involvement in adult acute myeloid leukaemia: report of five cases. (1977) (2)
Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma. (1991) (2)
Italian promotions defended ... (1992) (2)
Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN. (1989) (2)
Lenalidomide Is Effective in Heavily Pretreated Non Hodgkin Lymphoma (NHL): Analysis of a Retrospective Data Collection (2012) (2)
Scientific program and abstractT cell depletion with campath I to prevent GVHD after allogeneic bone marrow transplantation (1986) (2)
Serum Lactate Dehydrogenase Fails to Predict Response to Treatment and Survival in Acute Non-lymphocytic Leukemia (1989) (2)
Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study. (1991) (2)
T-cell depletion with the monoclonal antibody Campath 1 to prevent graft-versus-host disease in ten high-risk adult patients. (1986) (2)
Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119) (1990) (2)
[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]. (1993) (2)
CYTOGENETIC AND MOLECULAR ANALYSES IN PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (1988) (2)
Observations on the cytokinetics of chronic myeloid leukaemia. (1972) (2)
Molecular and cytogenetic studies of a patient with philadelphia‐negative, BCR‐positive chronic myeloid leukemia and t(12;12)(q13;p12) (1990) (2)
SPLENIC LYMPHOCYTES IN CHRONIC MYELOID LEUKÆMIA (1974) (2)
Cytogenetic monitoring in CML patients treated with BMT. (1989) (2)
No Preferential Sensitivity of t(8;21) Acute Myeloid Leukemias to Cytosine Arabinoside in Vitro: Is Intensity of Therapy or High Dose Ara-C Crucial for Response? (2004) (2)
VIABILITY OF AUTOLOGOUS BONE MARROW (1987) (2)
Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements: author reply (2009) (2)
Multiple myeloma in young patients. (1985) (2)
Supradiaphragmatic early stage Hodgkin's disease: does mantle radiation therapy still have a role? (1996) (2)
S-phase evaluation with bromodeoxyuridine in lymphocytes from cattle infected with bovine leukemia virus (BLV). (1989) (1)
Lenalidomide in Myelodysplastic Syndromes with 5q Deletion. Results From the Italian National Cancer Registry (2012) (1)
Anticytoskeleton autoantibodies and chronic graft versus host disease. (1985) (1)
A rapid reduction of Bcr/Abl transcripts is associated with an early cytogenetic response to Glivec (STI571) in chronic myeloid leukemia in chronic phase: a study of the Italian cooperative study group on CML (2001) (1)
Response to “Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions” by Heidel et al. (2018) (1)
[Polychemotherapy of Hodgkin's lymphoma. 3. Stage IV]. (1972) (1)
Italian survey on allogeneic BMT for chronic myeloid leukaemia. (1989) (1)
LITHIUM CARBONATE IN HÆMATOLOGY (1980) (1)
In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic bone marrow transplantation (1993) (1)
Anthracycline containing regimens in intermediate grade lymphoma. Italian Cooperative Study Group on Intermediate Grade Malignant Lymphoma. (1993) (1)
INTERFERON ALFA-2A FOR CHRONIC MYELOID LEUKEMIA. AUTHOR'S REPLY (1994) (1)
Kinetics variation of CD34+ and CD34+CD90+ in subjects following different mobilizing protocols. (2000) (1)
[Physiopathology, clinical features and therapy of thrombocytopenia]. (1989) (1)
Hyperdiploid clone in a patient with acute non-lymphocytic leukaemia (ANLL), previously treated with radio and chemotherapy for Hodgkin's lymphoma (HL). (1983) (1)
Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study. (2007) (1)
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)]. (1975) (1)
[Current knowledge of the relationships between the pancreas and iron metabolism]. (1967) (1)
DECREASING RISK OF LEUKAEMIA DURING PROLONGED FOLLOW-UP AFTER MITOBRONITOL THERAPY FOR POLYCYTHAEMIA VERA (1987) (1)
Stimulating factors in abnormal haematologic conditions. (1975) (1)
Expression of P21(WAF1/CIP1/SID1) cyclin-dependent kinase inhibitor in hematopoietic progenitor cells. (2001) (1)
Limiting dilution analysis of a novel tripeptide anticancer agent Ambamustine (PTT-119): effect on K-562, CCRF-SB and multidrug resistant LoVo-Dk cell lines. (1994) (1)
Combination Chemotherapy with Methotrexate, Endoxan, and Vincristine (M.E.V.) in the Treatment of non-Hodgkin's Lymphoma (1973) (1)
Prolonged bone marrow aplasia of refractory porolymphocytoid variant of B‐cell chronic lymphocytic leukemia related to fludarabine treatment (1994) (1)
Diagnosis with monoclonal antibodies of "T acute lymphoblastic leukaemia" expressing an unusual phenotype. (1982) (1)
[Staging classification of chronic lymphatic leukemia]. (1986) (1)
Percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura during pregnancy. (1998) (1)
Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease. (1999) (1)
The usefulness of routine immunological monitoring during the remission phase in acute lymphoblastic leukemias. (1988) (1)
Improvement of human myeloma stem cell growth in a liquid culture system supplemented with phytohemagglutinin. (1988) (1)
[Pancreatin and intestinal absorption of iron in sideropenic anemia]. (1966) (1)
Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment. (1991) (1)
Mafosfamide and bleomycin purging effects on normal marrow and K562 cells (1986) (1)
Thalidomide-Induced Peropheral Neuropathy in Newly Diagnosed and Pre-Treated Multiple Myeloma Patients. (2004) (1)
IRRELEVANT HEMOSTATIC TOXICITY OF ERWINASE AT INTERMEDIATE DOSE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY DATA (1994) (1)
Long-term survival in adult acute leukemia. A multicenter study of 56 patients. (1982) (1)
Lenalidomide Administration in Heavily Pretreated Patients with Non Hodgkin Lymphoma – First Report of the REVEAL Study (REVlimid® Effectiveness of Administration in patients with Lymphoma) (2011) (1)
The management of polycythaemia vera with dibromomannitol. (1970) (1)
T-lymphocyte subsets in healthy splenectomised patients. (1981) (1)
Retrospective Screening for HTLV I Infections in 68 Acute Leukemic Patients Multiply Transfused before 1985 1 (1990) (1)
Immune therapy of chronic myelogenous leukemia. (2005) (1)
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma (1990) (1)
[Cytogenetic study of paroxysmal nocturnal hemoglobinuria (PNH)]. (1973) (1)
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas (1990) (1)
Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph+ CML: update of the European Cooperative Study. (1991) (1)
Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial (2010) (1)
BCR-ABL breakpoint and prognosis in chronic myeloid leukemia. (1992) (1)
Unexpected presentation of deep candidiasis in a recipient of a mismatched bone marrow transplant. (1986) (1)
Acceleration of autologous hematopoietic recovery by GM-CSF after allograft rejection. (1989) (1)
Relationship between immunological response to alpha-IFN treatment in 35 patients with hairy cell leukemia. (1990) (1)
[Aspects of acute leukosis in adults]. (1961) (0)
Editor's/Publisher's Disclaimer (1998) (0)
A Randomized Study of MP versus Alternating VAD- VND(N=Mitoxantrone)/MP as Primary Therapy for Multiple Myeloma (1992) (0)
Transverse basilar cleft: Two more probable familial cases in an archaeological context (2020) (0)
COrticosteroid and/or immunosuppressive treatment in myelodysplastic syndromes: Retospective study of 13 patients (2000) (0)
[Trivalent iron in the treatment of hypochromic anemia]. (1957) (0)
[Desferrioxamine and heme synthesis. (Relations of desferrioxamine, protoporphyrin and blood)]. (1966) (0)
Karyotypic conversion by IFN as preparative treatment for ABMT in Ph positive CML (1993) (0)
[Evolution and therapy of blastic crises]. (1975) (0)
[Critical considerations of splenectomy for classification of clinical stages and planning of treatment of Hodgkin's disease]. (1973) (0)
[Cupremia and ceruloplasminemia in hemolymphopathies. II. Leukemias and polycythemia]. (1968) (0)
[Clinical applications of autologous bone marrow transplants. Results in non-Hodgkin lymphoma]. (1985) (0)
Chromosome radiation-induced aberrations in patients with Hodgkin's disease. Possible correlation with second malignancy? (1978) (0)
Slimming diet and the development of acute leukemia: a possible relationship? Report of three cases. (1997) (0)
[Drug therapy of pulmonary cancer]. (1973) (0)
Increasing doses of 60Co ionizing radiation produce different amounts of dicentrics depending on the dose rate. A possible model for irradiation schedules before bone marrow transplantation. (1987) (0)
[Fixed and soluble sulfhydryl groups of bone marrow in diabetic subjects treated with butylsulfanulurea]. (1957) (0)
Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy (1991) (0)
[Recurrent jaundice of pregnancy]. (1960) (0)
[Mathematic evaluation of hepatic function and of cholostasis before and after ligation of the choledochus of dogs, in relation to the morphological status of the liver]. (1960) (0)
Mixed lymphoid-myeloid leukemia presenting as acute lymphoblastic leukemia. (1984) (0)
Cell proliferation in acute promyelocytic leukemia. Studies with thymidine labeling and in vitro colony assay. (1982) (0)
Pancreatectomy and Iron Absorption (1967) (0)
[Bleeding after splenectomy; hemorrhagic thrombocythemia]. (1957) (0)
[DIAGNOSIS OF INTRAHEPATIC CHOLESTASIS]. (1963) (0)
[Direct experience with splenectomy in malignant lymphomas: analysis of 22 cases]. (1971) (0)
[Hepatic function tests in the diagnosis and prognosis of hepatitis]. (1967) (0)
Myelodysplastic Syndromes Myelodysplastic syndromes : recent advances (2001) (0)
[New directions in the prognostic evaluation of non-Hodgkin's lymphoma]. (1989) (0)
Non-Hodgkin's Lymphoma as Adjunct to Induction VNCOP-B Treatment of Elderly High-Grade Randomized Trial With or Without Granulocyte Colony-Stimulating Factor (2013) (0)
Foreword (1989) (0)
[Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia]. (1972) (0)
Septicaemia after splenectomy for Hodgkin's disease: two episodes in the same patient, 9 and 13 years after cure. (1988) (0)
[Cytological and cytochemical modifications of hemopoietic tissue in animals treated by butylsulfanilurea]. (1957) (0)
Subject Index Vol. 106, 2001 (2002) (0)
[Research on the effects of selenium & cysteine on chicken erythroblastosis]. (1958) (0)
Allogeneic Bone Marrow Transplantation for Leukemias and Hematologic Malignancies in Bologna (1985) (0)
[Morphological and cytochemical changes induced in the animal organism by the administration of ethylenimine quinone]. (1956) (0)
Effect of etoposide (VP 16-213) on normal CFU-GM growth pattern. (1987) (0)
208 Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. Preliminary report from the prospective MDS0306 GIMEMA trial (2011) (0)
Subject Index, Vol. 74, 1985 (2004) (0)
High-dose therapy followed by autologous bone marrow transplantation in previously untreated high grade non-Hodgkin's lymphoma: 10-year long-term results. (1995) (0)
Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative Group. (1989) (0)
Contents, Vol. 10, 1957 (1957) (0)
[Thrombocythemia. General considerations]. (1991) (0)
Sex and prognosis in adult acute lymphoblastic leukaemia. (1978) (0)
[Hemorrhagic syndrome with hyperthrombocythemia appearing after splenectomy]. (1957) (0)
[Deficiency of sulfhydryls in pathogenesis of tuberculous erythropathy]. (1957) (0)
Recombinant Human Erythropoietin After Bone Marrow Transplantation — A Placebo Controlled Trial (1996) (0)
[Allogeneic bone marrow transplantation in two patients with marrow aplasia. Clinical and hematological aspects (author's transl)]. (1977) (0)
[Distribution of sulfhydril substances in the cells of epithelial neoplasms]. (1957) (0)
[Non-Hodgkin's lymphomas (analysis of clinicopathological results of 207 cases) (author's transl)]. (1976) (0)
[Determination of alkaline phosphatase isoenzymes in the definition of the clinical stage of Hodgkin's disease]. (1972) (0)
Mopp chemotherapy in the treatment of stage IV Hodgkin's disease. (1985) (0)
Haemorheology in treated polycythaemia vera: The role of hypochromic mycrocytosis and of plasma viscosity (2016) (0)
[Neurosecretion, liver disease and somatotrophic hormones; effect of somatotropin on hypothalamo-pituitary neurosecretion and on the liver of rats in normal conditions and in experimental chronic carbon-tetrachloride poisoning; histochemical study]. (1956) (0)
Clinical and Biological Aspects of Essential Thrombocythemia (1985) (0)
POLYCYTHÆMIA AND IRON DEFICIENCY IN PULMONARY " EMPHYSEMA " (1964) (0)
[Effects of serotonin on the hepatic uptake of bromsulphalein]. (1960) (0)
[Sulfhydryl compounds in the bone marrow and blood of leukemic patients; cytochemical research]. (1955) (0)
[Sulfur and sulfhydryl groups (fixed and soluble) in physiopathology of the endocrine glands]. (1958) (0)
PHP26 CLASSIFICATION AND REGRESSION TREES HELP IN DEVELOPING EMBEDDED EVIDENCEAND CONSENSUS-BASED GUIDELINES (2002) (0)
Hemostatic Abnormalities Related Marrow Transplant ation to Bone (1992) (0)
[Relations between digitalis and sulfhydryl compounds: experimental comparative electrocardiographic and morphological study between digitalis and iodoacetamide; protective effects of cysteine in digitalis poisoning]. (1957) (0)
“PCR fingerprinting” of HLA class I (A,B,C) genes (1994) (0)
[Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma]. (1968) (0)
[Evaluation of depot iron in polycythemia]. (1967) (0)
[Effect of glycogen & insulin on erythropoiesis in chick embryo]. (1957) (0)
[Granulopoiesis in "smouldering" leukemias in vitro]. (1975) (0)
[Thrombocythemias (author's transl)]. (1979) (0)
responders : a study of complete cytogenetic α Chronic myeloid leukemia and interferon- (2013) (0)
[Nephropathy as the cause of anemia and polyglobulism]. (1959) (0)
[Research on the nature of anemia during rheumatoid arthritis: porphyrin metabolism and iron exchange]. (1962) (0)
Contents, Vol. 80, 1988 (1988) (0)
Congenital dyserythropoietic anemia type II: serologic and morphologic family study. (1979) (0)
Chronic T‐cell leukaemias. A variant of T‐prolymphocytic leukaemias: morphological, immunological and clinical characterization of 2 cases (1987) (0)
[Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow]. (1982) (0)
[Clinico-hematological aspects in medullary metastases of non-lymphomatous solid tumors]. (1980) (0)
[The kinesis of bromosulfalein (quantitative determination of hepatic function and cholestasis)]. (1965) (0)
[Cytotopochemical observations on the sulfhydryl group content of blood and bone marrow in leukemic subjects]. (1955) (0)
preparation for autologous transplantation for multiple myeloma vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in Superiority of thalidomide and dexamethasone over (2013) (0)
Interferon-α2b is not effective in the treatment of refractory immune thrombocytopenic purpura (1998) (0)
[Progress and problems in the treatment of acute myeloid leukemia: analysis of 92 cases]. (1976) (0)
Contents, Vol. 74, 1985 (1985) (0)
[On a new method for the evaluation of the functioning hepatic mass and the cholostatic index by means of bromsulphalein]. (1960) (0)
Human CD86+ acute myeloid leukemia cells rapidly differentiate into dendritic cells unable of inducing cytotoxic T cell responses. (1999) (0)
[Antibiotic therapy in the high risk patient (hematologic study)]. (1976) (0)
Case report of 11q- in M2-acute nonlymphocytic leukemia. (1984) (0)
AZT+methotrexate in high-grade HIV-related non-Hodgkin lymphomas: interim report on feasibility and tolerance. (1995) (0)
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)]. (1978) (0)
[The immune system in Hodgkin's disease. Preliminary observations on cutaneous reactivity to tubercular antigens]. (1970) (0)
Optimal Timing of Autologous Bone Marrow Transplantation for Patients with Hodgkin’s Lymphoma1 (1989) (0)
[Polycythemic hyperviscosity syndromes]. (1983) (0)
ppropriate use of bendamustine in first-line therapy of chronic ymphocytic leukemia . Recommendations from SIE , SIES , GITMO roup (2014) (0)
Lymphocytes Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p 27 kip 1 (2002) (0)
[ANEMIC SYNDROMES IN PATIENTS GASTRECTOMIZED FOR GASTRODUODENAL ULCER]. (1963) (0)
[Hematomedullary sulfhydryl groups, fixed and soluble, in liver disease patients]. (1957) (0)
[Sulfhydryl groups in components of blood and marrow of subjects with neoplasms and malignant granuloma; cytotopochemical research]. (1955) (0)
In vitro exposure of leukemic cells to low concentration arabinosyl cytosine: No evidence of differentiation inducing activity (1987) (0)
Interferon gamma in chronic myeloid leukemia: dose and side effects. (1988) (0)
Hepato-splenomegalic cirrhosis associated with lymphoreticulosis and hyperproteinemia. (1960) (0)
Letter: Philadelphia-chromosome-positive preleukaemic state. (1973) (0)
Hemostatic Abnormalities Related to Bone Marrow Transplantation (1992) (0)
European Cooperative Group for Bone Marrow Transplantation Bone marrow transplantation in multiple myeloma: report from the (2011) (0)
[GM-CSF: its use in onco-hematologic diseases]. (1989) (0)
Indolent Lymphomas (2000) (0)
The impact of the source of stem cells on the outcome of Autologous Stem Cell Transplantation (ASCT) for patients with myelodysplastic syndrome or acute myeloid leukemia following MDS (2001) (0)
[MORPHOFUNCTIONAL ASPECTS OF THE LIVER IN THE COURSE OF ACUTE CHOLESTASIS]. (1965) (0)
Observations on the Intradermal Test with Streptococcal Antigen in High Doses. (1960) (0)
Reply to the letter of S. Serke (1989) (0)
[Exudative lymphogranulomatous pneumonia with rapid fatal outcome following extensive supradiaphragmatic cobalt therapy]. (1970) (0)
[ANEMIC SYNDROMES OF PATIENTS WITH GASTRIC RESECTION FOR GASTRO-DUODENAL ULCER]. (1963) (0)
BCR-ABL breakpoint and prognosis in chronic myeloid leukemia [letter; comment] (1992) (0)
[Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl)]. (1979) (0)
[Daunomycin alone and in association with other drugs in the therapy of acute myelomonoblastic leukemia in the adult]. (1969) (0)
Breakthrough in supportive cancer care : introducing Pegfilgrastim (2004) (0)
The Use of Hematopoietic Growth Factors in the Treatment of Malignant Lymphomas (1994) (0)
[THE KINETICS OF BROMSULPHALEIN. QUANTITATIVE DETERMINATION OF LIVER FUNCTION AND CHOLESTASIS]. (1963) (0)
[Comparative study of the methods of stimulation of intrinsic factor]. (1967) (0)
Chronic Idiopathic Thrombocytopenic Purpura (ITP) 51-Cr-Platelet Kinetics and Splenectomy in 197 Patients (1979) (0)
An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience. (1987) (0)
[Study of hepatic function in some skin diseases]. (1960) (0)
[Immunity and leukemia. II. Immunological pattern of lymphocytes in chronic lymphatic leukemia]. (1971) (0)
previously untreated patients with follicular lymphoma Monitoring of minimal residual disease after CHOP and rituximab in (2013) (0)
[Preliminary studies on the immunoreactivity of splenectomized patients with malignant granuloma]. (1972) (0)
[Sprue syndrome and malignant lymphoma. 1 case]. (1970) (0)
Delayed hypersensitivity and Ig level in 210 patients with chronic myeloid leukemia (1979) (0)
Unusual evolution and chromosome aberrations in a patient with myelofibrosis with myeloid metaplasia. (1985) (0)
Contents, Vol. 62, 1979 (1979) (0)
VNCOP-B Regimen Experience on 350 Patients Elderly Aggressive-Histology Non-Hodgkin's Lymphoma: First-Line (2013) (0)
[ANEMIC SYNDROMES OF PATIENTS GASTRECTOMIZED FOR GASTRO-DUODENAL ULCER]. (1964) (0)
Bestimmung der « Plasma-clearance », des « Leberfunktions-Index » und des « cholostatischen Index » mittels Bromsulphalein (1963) (0)
Pcr-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation (2000) (0)
Contents Vol. 106, 2001 (2002) (0)
[THE KINETICS OF BROMSULPHALEIN. QUANTITATIVE DETERMINATION OF LIVER FUNCTION AND CHOLESTASIS]. (1963) (0)
[Subcutaneous development of Walker carcinoma in rats fed deficient diets and with injured livers]. (1958) (0)
All-Trans Retinoic Acid in the Treatment of Myelody splastic Syndromes (1995) (0)
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals the existance of two subgroups related to different cellular counterparts. (2005) (0)
[FUNCTIONAL AND BIOPTIC STUDY OF THE LIVER IN PATIENTS EXPOSED TO FLUOTHANE ANESTHESIA]. (1964) (0)
[Action of dihydroergotamine on the arterial pressure of rats with chronic renal hypertension]. (1967) (0)
[Possibilities & limitations of cyto & histological diagnosis in lymph node disease; comparative study of cytology in contrast with histology]. (1957) (0)
Chronic Leukemia (2020) (0)
Vindesine effect in myeloid leukemia (2004) (0)
[Remarks on the relationships of the exocrine pancreas with the digestive absorption of iron]. (1967) (0)
186 Intensive antileukemic treatment and/or allogeneic or autologous bone marrow or PBSC transplantation in myelodysplastic syndromes and in post-MDS acute myeloid leukaemia (1997) (0)
Culture conditions that stimulate expansion of normal hematopoietic progenitors from chronic myelogenous leukemia marrow (1997) (0)
Clinical Study with Human Recombinant Interferon-α2a in Chronic Myeloid Leukemia. Protocol of the Italian Cooperative Study Group on Chronic Myeloid Leukemia: Preliminary Analysis of Results (1993) (0)
[On chronic lymphatic leukemia and its therapy: study of 40 cases]. (1970) (0)
[Roentgen irradiation & sulfhydryl groups; protective action of cysteamine, sodium hyposulfite & vitamin B12 on the hemolymphopoietic organs, the liver, the pancreas & the adrenal glands]. (1957) (0)
Subject Index, Vol. 80, 1988 (1988) (0)
[Use of total radiotherapy in Hodgkin's lymphoma]. (1972) (0)
Dendritic cells Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation (2002) (0)
Chromosome patterns of relapses following allogeneic bone marrow transplantation for acute non-lymphocytic leukemia. Description of three cases. (1987) (0)
Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia. (1988) (0)
[Action of ethyleneiminoquinones on sulfhydryl groups of bone marrow and liver]. (1956) (0)
Acute Graft-versus-Host Disease and Steroid Treatment Impair CD11c (cid:1) and CD123 (cid:1) Dendritic Cell Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation (2004) (0)
Molecular R emission A fter A llogeneic o r A utologous Transplantation o f H ematopoietic S tem C ells f or Multiple M yeloma (2000) (0)
[Pathogenetic factors in myelosclerosis; two case reports]. (1958) (0)
study : Presented in part at the 43rd Annual Meeting of The American chronic myelogenous leukemia in myeloid blast crisis: results of a phase II Imatinib induces hematologic and cytogenetic responses in patients with (2013) (0)
Treatment of Ph-Positive Chronic Myeloid Leukemia with a-Interferon (Roferon-A) . The Italian Cooperative Study Group Experience THE ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA* Presented by S. TURA (1993) (0)
[Essential thrombocythemia: in vitro study of megakaryocytopoiesis]. (1991) (0)
[Chromatographic study of the metabolities of bromsulphalein after administration of sodium dehydrocholate]. (1962) (0)
[Report on benzene-induced erythrocyte disorders]. (1958) (0)
[Action of papaverine on the arterial pressure of rats with chronic renal hypertension]. (1967) (0)
[USE OF DESFERRIOXAMINE B IN DIAGNOSIS AND THERAPY OF HYPERSIDEROSIS]. (1964) (0)
Evaluation of Platelet Production by 75Se-IHethionine (75Se-Me) in Patiente with Bone Marrow Failure and Preleukaemia (1975) (0)
A25 The prognostic profile of the patients is essential for any comparative interpretation of clinical trials (1996) (0)
Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy. (1990) (0)
leukemia trials with interferon-alpha (letter) comparative analysis of the Italian and German chronic myeloid Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a (2013) (0)
[Essential thrombocythemia: therapy with alpha interferons]. (1991) (0)
Author Index/Subject Index (2019) (0)
Combination treatment of post-transplant lymphoproliferative disorders (PTLDs) in liver transplant (OLT) recipients (2002) (0)
[Effects of cortisone and prednisolone on various organs and tissues]. (1956) (0)
Allogeneic bone marrow transplantation for multiple myeloma. (1989) (0)
High-dose chemotherapy/ABMT in 72 patients with advanced resistant Hodgkin's disease (HD). An Italian study group (1988) (0)
[On the use of daunomycin in the therapy of acute leukemias]. (1969) (0)
[Some data on the intradermal test with streptococcal antigen in large doses]. (1960) (0)
[Presentation of the Centro di Pneumologia Tommaso Campanacci]. (1973) (0)
Contents, Vol. 50, 1973 (1973) (0)
[Action of colchicine and nitrogen mustard on cellular thiol groups in liver]. (1956) (0)
[Lymphadenographic and histopathological comparison of lumbo-aortic lymph nodes in Hodgkin's lymphoma]. (1972) (0)
[Diagnosis of hepatic localization of Hodgkin's lymphoma]. (1972) (0)
[Splenectomy in the therapy of malignant lymphomas]. (1971) (0)
Prognostic value of karyotype in common acute lymphoblastic leukemia of the adult. (1984) (0)
[Distribution of the sulfhydryl groups in cellular elements of lymph nodes attacked by malignant granuloma and reticulosarcoma]. (1956) (0)
Subject Index Vol. 95, 1996 (1996) (0)
Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype. (1991) (0)
[ANEMIC SYNDROMES IN PATIENTS GASTRECTOMIZED FOR GASTRODUODENAL ULCER]. (1964) (0)
Tγ Cell Deficiency in Idiopathic Thrombocytopenic Purpura (ITP) (2009) (0)
Contents, Vol. 95, 1996 (1996) (0)
HLA molecular typing for selection of unrelated bone marrow donors (1994) (0)
[Contribution to the knowledge of correlations between blood serum electrophoretic aspects and morphological findings of the liver and bone marrow in the course of liver cirrhosis]. (1959) (0)
Contents, Supplement 1, 1984 (1984) (0)
Subject Index, Vol. 62, 1979 (1979) (0)
Prostatic lymphoma. (1983) (0)
[Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma]. (1972) (0)
Effects of alpha-IFN on chronic myeloid leukemia (CML) hematopoiesis maintained in long-term cultures. (1991) (0)
The role of interferon alpha-2a in the treatment of cutaneous T-cell lymphomas (1993) (0)
[Hemoglobin increase in severe sideropenic anemia. Response to therapy with oral and intravenous sodium ferric gluconate]. (1986) (0)
Immunotherapy with BCG and leukemic blast cells during complete remission of acute myeloid leukemia. (1977) (0)
[Antidiuretic action of the cerebrospinal fluid in diabetes mellitus]. (1955) (0)
Dibrommanitol for chronic myeloid leukaemia. (1969) (0)
[Therapy of multiple myeloma: present and future]. (1986) (0)
[Selective celiac-splenic arteriography in determination of the stage of Hodgkin's lymphoma]. (1972) (0)
[Pseudoleukemic splenic tuberculosis. Casuistic contribution]. (1960) (0)
Index rerum ad Vol. 50 (1973) (0)
[Immunity, leukemias and lymphomas. 3. Immune reactions in malignant granuloma in relationship to the clinical stage of the disease]. (1972) (0)
Early A utologous S tem-Cell T ransplantation V ersus Conventional C hemotherapy a s F ront-Line T herapy i n H igh- Risk, A ggressive N on-Hodgkin's L ymphoma: A n I talian Multicenter R andomized T rial (2003) (0)
Serum lysozyme level in adult acute non-lymphoid leukaemia. (1979) (0)
Quality of Life in Elderly Patients with Essential Thrombocythemia. (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sante Tura?

Sante Tura is affiliated with the following schools:

Sante Tura's Academic­Influence.com Rankings

Why Is Sante Tura Influential?

Sante Tura's Published Works

Published Works

What Schools Are Affiliated With Sante Tura?

Sante Tura's AcademicInfluence.com Rankings